Sweden will stop the sale of diclofenac, a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation, over-the-counter due to fears of health failure. Diclofenac is the ingredient in Volatren, Ignorin, and Eeze in Sweden. Starting June, 1, 2020 diclofenac pills and capsules are available via prescription only.
A major study in 2018 revealed a small risk of atrial fibrillation, stroke, heart failure, heart attack and death due to cardiovascular disease even among those patients using relatively low doses (e.g. less than 100 mg/day) during short periods of treatment warned the Swedish Medical Products Agency.
Lead Investigator at Swedish Medical Products Agency
The new study evidences the theory of “increased risk of cardiovascular side effects that have been known to exist for some time, even at lower doses and short-term use,” reported Paulina Tuvendal, clinical investigator, at the agency.
Paulina Tuvendal, Swedish Medical Products AgencySource: The Local